Biomedical Engineering Reference
In-Depth Information
and angiotensin-converting enzyme in human atria during atrial i brillation. J. Am.
Coll. Cardiol. 35: 1669-1677.
Hammwöhner, M. and A. D'Alessandro, O. Wolfram, and A. Goette. 2007a. New
pharmacologic approaches to prevent thromboembolism in patients with atrial
i brillation. Curr. Vasc. Pharmacol. 5: 211-219.
Hammwöhner, M. and A. Goette. 2008. Will Warfarin Soon Be Passe? New Approaches to
Stroke Prevention in Atrial Fibrillation. J Cardiovasc. Pharmacol. 52: 18-27.
Hammwöhner, M. and A. Ittenson, J. Dierkes, A. Bukowska, H.U. Klein, U. Lendeckel,
and A. Goette. 2007b. Platelet Expression of CD40/CD40 Ligand and Its Relation to
Inl ammatory Markers and Adhesion Molecules in Patients with Atrial Fibrillation. Exp.
Biol. Med. (Maywood) 232: 581-589.
Hammwöhner, M. and J. Tautenhahn, D. Kuester, and A. Goette. 2008. Inadvertend catch
of a factor VIII rich thrombus with a femoral sheath during cardiac catheterization. Int.
J. Cardiol. 130: e39-e41.
Kamiyama, N. 1998. Expression of cell adhesion molecules and the appearance of adherent
leukocytes on the let atrial endothelium with atrial i brillation: rabbit experimental
model. Jpn. Circ. J. 62: 837-843.
Kawamura, T. and T. Umemura, A. Kanai, M. Nagashima, N. Nakamura, T. Uno, M.
Nakayama, T. Sano, Y. Hamada, J. Nakamura, and N. Hotta. 2006. Soluble adhesion
molecules and C-reactive protein in the progression of silent cerebral infarction in
patients with type 2 diabetes mellitus. Metabolism 55: 461-466.
Kim, Y.M. and T.J. Guzik, Y.H. Zhang, M.H. Zhang, H. Kattach, C. Ratnatunga, R. Pillai,
K.M. Channon, and B. Casadei. 2005. A myocardial Nox2 containing NAD(P)H oxidase
contributes to oxidative stress in human atrial i brillation. Circ. Res. 97: 629-636.
Mihm, M.J. and F. Yu, C.A. Carnes, P.J. Reiser, P.M. McCarthy, D.R. Van Wagoner, and J.A.
Bauer. 2001. Impaired myoi brillar energetics and oxidative injury during human atrial
i brillation. Circulation 104: 174-180.
Minamino, T. and M. Kitakaze, S. Sanada, H. Asanuama, T. Kurotobi, Y. Koretsune, M.
Fukunami, T. Kuzuya, N. Hoki, and M. Hori. 1998. Increased expression of P-selectin
on platelets is a risk factor for silent cerebral infarction in patients with atrial i brillation:
role of nitric oxide. Circulation 98: 1721-1727.
Noutsias, M. and C. Hohmann, M. Pauschinger, P.L. Schwimmbeck, K. Ostermann, U. Rode,
M.H. Yacoub, U. Kuhl, and H.P. Schultheiss. 2003. sICAM-1 correlates with myocardial
ICAM-1 expression in dilated cardiomyopathy. Int. J. Cardiol. 91: 153-161.
Schild, L. and A. Bukowska, A. Gardemann, P. Polczyk, G. Keilhof , M. Tager, S.C. Dudley,
H.U. Klein, A. Goette, and U. Lendeckel. 2006. Rapid pacing of embryoid bodies impairs
mitochondrial ATP synthesis by a calcium-dependent mechanism—a model of in
vitro dif erentiated cardiomyocytes to study molecular ef ects of tachycardia. Biochim.
Biophys. Acta 1762: 608-615.
Shinagawa, K. and H. Mitamura, S. Ogawa, and S. Nattel. 2002. Ef ects of inhibiting
Na(+)/H(+)-exchange or angiotensin converting enzyme on atrial tachycardia-induced
remodeling. Cardiovasc. Res. 54: 438-446.
Sohara, H. and S. Amitani, M. Kurose, and K. Miyahara. 1997. Atrial i brillation activates
platelets and coagulation in a time-dependent manner: a study in patients with
paroxysmal atrial i brillation. J. Am. Coll. Cardiol. 29: 106-112.
